Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuraxis (NRXS) Shares Outstanding (Diluted Average) (2022 - 2025)

Historic Shares Outstanding (Diluted Average) for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to $9.9 million.

  • Neuraxis' Shares Outstanding (Diluted Average) rose 3772.59% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 3772.59%. This contributed to the annual value of $6.9 million for FY2024, which is 11273.64% up from last year.
  • Latest data reveals that Neuraxis reported Shares Outstanding (Diluted Average) of $9.9 million as of Q3 2025, which was up 3772.59% from $8.5 million recorded in Q2 2025.
  • In the past 5 years, Neuraxis' Shares Outstanding (Diluted Average) registered a high of $9.9 million during Q3 2025, and its lowest value of $2.0 million during Q2 2022.
  • Over the past 4 years, Neuraxis' median Shares Outstanding (Diluted Average) value was $5.1 million (recorded in 2023), while the average stood at $5.0 million.
  • Per our database at Business Quant, Neuraxis' Shares Outstanding (Diluted Average) soared by 168.87% in 2023 and then surged by 24547.64% in 2024.
  • Neuraxis' Shares Outstanding (Diluted Average) (Quarter) stood at $2.0 million in 2022, then soared by 62.35% to $3.3 million in 2023, then surged by 112.74% to $6.9 million in 2024, then surged by 42.77% to $9.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $9.9 million in Q3 2025, compared to $8.5 million in Q2 2025 and $7.5 million in Q1 2025.